Carregant...
Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial
BACKGROUND: Necrotizing enterocolitis (NEC) is one of the most severe complications in very preterm infants, but there are currently no accepted methods to prevent NEC. Studies have shown that erythropoietin (EPO) has the potential to prevent NEC or improve outcomes of preterm NEC. This study aimed...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7414749/ https://ncbi.nlm.nih.gov/pubmed/32771013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02459-w |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|